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Introduction 
Laparoscopy (Lapor-flank, scope-to look) 1  is a  modern, minimally  
invasive surgical /diagnostic procedure, in which abdominal cavity is visualized 
with a scope. This surgery can be performed with minimal surgical incision 
thereby leading to less pain, less paralytic ileus, short hospital stay and  early 
ambulation. 
History 
460-570 BC - Hippocrates-rectal examination with speculum2 
1773 - Philip bozzini found lichtleiter-redirect light from cavity of 
illumination to the viewer eye  
1902  - George kelling - koelioscopie & laparoscopy to dog  
1910 - Christian jacobeus-first laparoscopy in human, coined the name 
laparothorocoskopie 
1982  - Kurt semm- insufflators &Harold Hopkins-fibro  
   optics 
1987  -  Philippe Mouret- first laparoscopic  
   cholecystectomy. 
1994  - Robotic   laparoscopic surgery. 
PAIN  
 “THE PAIN OF SURGERY WAS TORTUROUS”  said by Celsus in the 
pre anaesthetic era.  
Pain is a Greek word derived from the name POINE, the Greek  
Goddess of revenge.  
DEFINITION OF PAIN: 
International Association for the Study of pain has defined“pain as an  
unpleasant sensory and emotional experience associated with actual or potential  
tissue damage. Pain is always underestimated and under treated. Pain relief is an 
important goal of Anaesthesia. 
Any degree of pain is significant to a patient. It is argued that any amount of 
reduction in the pain is beneficial, when the treatment is not associated with any 
adverse effect. It makes a difference in duration of hospital stay and time of 
ambulation.  
PAIN IN LAPAROSCOPIC SURGERY: 
In abdominal surgeries, the cause of pain is 
                                             1. Somatic   
                                             2. Visceral.3  
Somatic pain is due to skin incision and the visceral pain is due to handling 
of the intestine and peritoneal inflammation.  During open surgeries, both somatic 
and visceral pain will be present which may not be tolerable to a patient with out 
adequate analgesia.  In Laparoscopic surgeries somatic pain is very less due to a 
small skin incision. But visceral pain is more prominent due to visceral nociceptor 
stimulation .Visceral Pain may occur due to rapid distension of peritoneum, 
intraperitoneal inflammation, traction of nerves and vessels, diaphragmatic 
irritation (shoulder tip pain). 
Post laparoscopic pain can be minimized by following ways1: 
-  creating the pneumoperitoneum slowly ,  
- aspiration of gas under the diaphragm which lets out the residual CO2 ,  
- keeping gas drain,  
- using low pressure and heated gas,  
- using nitrous oxide pneumoperitoneum,  
- instillation of local anaesthetics  under the diaphragm,  
- rectus sheath block,  
- surgery under subarachnoid block,  
- peri- operative  NSAID’S and opioids.      
Intra peritoneal local anaesthesia is a simple, cheap and safe method of 
providing post operative analgesia. 
MECHANISM OF ANALGESIA: 
Intraperitoneal local anaesthetics acts by blocking the visceral nociceptors, 
thereby, decreasing the visceral pain in laparoscopic surgeries. It also has anti 
inflammatory action and prevents peritonitis and bowel adhesion. Visceral 
nociceptors will be stimulated by handling of the viscera and the peritoneum 
causing inflammation and pain. 
AIM OF THE STUDY 
Aim of the study is to evaluate the efficacy of intraperitoneal instillation of 
local  anaesthetics  for  post  operative  pain  relief  after  laparoscopic  abdominal 
surgeries  and  compare  the  efficacy  of  two  different  local  anaesthetics‐
Bupivacaine vs Ropivacaine in terms of 
1.   Duration of post operative pain relief 
2.   24 hour post operative analgesic requirement 
3.   Post operative nausea and vomiting  
4.   Post operative hemodynamic changes like pulse rate, Blood pressure.  
5.   Complications 
LAPAROSCOPIC SURGERY AND ANAESTHESIA4: 
Laparoscopic surgeries are minimal invasive surgeries during which an inert 
gas is insufflated into the abdomen to diagnose and operate. It is used in 
gastrointestinal, gynecological , urological and vascular surgeries. 
PHYSIOLOGICAL CHANGES DURING LAPAROSCOPY: 
During laparoscopy certain patho physiological changes occurs in the 
patients. Creation of pneumoperitoneum and alteration of patient position 
predispose to these changes. 
                                LAPAROSCOPIC SURGERY 
              
   
           
                           
 
 
 
 
CHANGES THAT OCCUR DUE TO PNEUMOPERITONEUM: 
Respiratory changes: 
Insufflation of gas into the peritoneal cavity causes decrease in thoroco-
pulmonary compliance, basal atelectasis due to elevation of diaphragm, decrease in 
functional residual capacity leading to ventilation perfusion mismatch.PaCO2 will 
increase progressively and will reach a plateau in 15 to 30 minutes after CO2 
pneumoperitoneum.  
Causes of increase in PaCO2 is multifactorial. This might be due 
• to impaired ventilation, 
• absorption of CO2 from the peritoneum,  
• ventilation perfusion mismatch and 
• Patient positioning.  
If laparoscopy is done under local anesthesia, this hypercapnia will be 
compensated by increase in respiratory rate in such spontaneously breathing 
patients.  
Cardiovascular changes with pneumoperitoneum: 
 In laparoscopic surgeries, marked hemodynamic changes occur in 
cardiovascular system due to the effect of CO2 absorption, positioning of the 
patient, anesthetic agents and pneumoperitoneum  
per se. 
When the intra abdominal pressure is >10mmhg, it will cause inferior vena 
caval compression and pooling of blood in the lower extremities, which decreases 
the venous return to the heart thereby reducing the cardiac output. 
 Degree of change in cardiac output depends upon the change in the intra 
abdominal pressure. When the intra abdominal pressure is < 10mmHg, 
hemodynamic alteration is not significant. Significant alteration in hemodynamics 
occurs, when the intra abdominal pressure is > 10 mmHg after insufflation. 
 Increase in intra-abdominal pressure also increases intra thoracic pressure, 
which increases the peripheral vascular resistance. Mechanical stimulation of 
peritoneal receptor releases catecholamines and vasopressin, which contributes to 
increase in the peripheral vascular resistance. 
 Arrhythmias can also occur during laparoscopy. Sudden stretching of the 
peritoneum will stimulate the vagus nerve inducing arrhythmias including 
bradycardia and asystole. 
Changes in the regional blood flow 
 Due to pneumoperitoneum and head up position, venous stasis in the lower 
extremities can occur, which may predispose to deep vein thrombosis. It also 
decreases the renal blood flow, glomerular filtration, and urine output. But after 
deflating the abdomen, renal blood flow increases and hence the urine output. 
PROBLEMS DUE TO POSITIONING: 
Cardio Vascular system:  
 Due to head down position, there will be a rise in central venous pressure 
which in turn raises the cardiac output. Stimulation of baroreceptors causes 
systemic vasodilatation and bradycardia. This position also increases intracranial 
tension and intra ocular tension. 
Respiratory system 
 Head down position causes elevation of the diaphragm which may cause 
basal atelectasis, reduction in functional residual capacity and lung compliance. It 
also increases the airway pressure. These changes are more marked in obese, old 
and debilitated patients. 
Nerve compression:    
 Head down position may cause hyper abduction of the arm, which 
predisposes to brachial plexus injury. If the patient is placed in lithotomy position 
for a long time (gynecological surgeries), it may injure the common peroneal 
nerve. 
ANAESTHETIC TECHNIQUES 
Laparoscopic surgery can be done under 
                        1. Local anaesthetic infiltration 
                        2. Epidural anaesthesia 
                        3. Spinal anaesthesia 
                        4. General anaesthesia 
LOCAL ANAESTHESIA: 
 In local anaesthesia with intravenous sedation, short gynaecological 
procedures like laparoscopic sterilization can be done. 
 
ADVANTAGES: 
• Early recovery 
• Less post operative Nausea and vomiting. 
• Less hemodynamic changes 
• Early diagnosis of complications. 
 
DISADVANTAGES: 
• Patients anxiety 
• Pain 
 
Regional anaesthesia: 
 In laparoscopic surgery under Epidural and spinal anaesthesia, muscle 
relaxation will be very good but a higher level is needed. Post operative shoulder 
tip pain will not be present in epidural or spinal anaesthesia.  
Advantages: 
• Less usage of sedatives and Narcotics. 
• Good muscle relaxation 
• Less shoulder tip pain 
• Good post operative pain relief 
COMPLICATIONS:  
 Complications are common after any surgery. Laparoscopic surgery is not an 
exception either. Complications common with laparoscopic surgeries are   
• Pneumo thorax. 
• Pneumo mediastinum 
• Pneumo pericardium  
• Endo bronchial intubation – due to endotracheal tube migration 
• CO2 gas embolism 
• Risk of Aspiration. 
• Intestinal injuries 
• Vascular injuries 
 Although all the above mentioned complications are related to surgery, 
Anaesthetists must   be adequately prepared to diagnose and respond to the 
complications. 
Post operative changes after laparoscopic surgery: 
Stress response: 
 Though Laparoscopic surgeries are less invasive, the stress response that 
occurs in a patient  undergoing  Laparoscopic surgery is similar to an open surgery. 
Plasma cortisol, catecholamine level, urinary cortisol, urinary catecholamine level 
were same after both surgeries. 
Post operative pulmonary dysfunction: 
Postoperative respiratory dysfunction is less after laparoscopic procedure 
than open procedures. It is more common after upper abdominal laparoscopic 
surgeries than pelvic laparoscopic surgeries. It is more severe in older patients, 
known COPD patients and obese patients. 
Pain: 
Post operative pain is more in open abdominal surgeries. Laparoscopic 
surgery allows a greater reduction in post operative pain and analgesic 
consumption. After a Laparoscopic surgery, patients complain more of visceral 
pain (Biliary colic, pelvic spasm and shoulder tip pain) than parietal pain. 
 
Post operative Nausea & Vomiting: 
Intra operative opioid and Nitrous oxide contributes to postoperative nausea 
and vomiting.  Intraoperative propofol use for induction, draining the gastric 
contents, intraoperative use of Droperidol, transdermal scopolamine all can reduce 
post operative nausea and vomiting markedly. 
Alternatives to CO2 Pneumo peritoneum: 
1.  Helium gas 
2.  Argon gas 
3. Nitrous oxide Pneumo peritoneum 
4. Gasless Laparoscopy – Abdominal wall lift method 
 
 
 
          
PHARMACOLOGY OF BUPIVACAINE5 
BUPIVACAINE 
                        
   
 
 
 
 
Bupivacaine is an amide group of local anaesthetic agent.  
A.F.EKENSTAM first used Bupivacaine. 
 
PHYSIO CHEMICAL PROPERTIES 
 It is 1-butyl pipecoloxylidide. Clinically it is used as a racemic mixture 
containing both ‘R’ and ’S’ form.  
It has a longer duration of action, moderate onset of action, highly potent, 
highly plasma protein bound, highly lipid soluble.  It crosses the placenta and 
blood brain barrier because of its high lipid solubility.  
 
                                 
                                                                       
                                                                  
BUPIVACAINE 
 
 
1.  Pka    - 8.1 
2.  Molecular weight  - 288 
3. Protein binding   - 95% 
4. Lipid solubility   - 28 
5. Elimination half life  - 210 minutes  
  6. Toxic plasma concentration - 5 to 10µg/ml 
 
MECHANISM OF ACTION: 
 Bupivacaine acts by blocking the voltage gated sodium channels in the 
neurons and delays the process of depolarisation. 
 
 
 
VOLTAGE GATED SODIUM CHANNEL 
                                     
                                  
 
 
 
 
 
 
 
  
 
 
PHARMACO KINETICS: 
Absorption:   
 It mainly depends upon the site of injection, dosage, volume, addition of 
vasoconstrictors.  Due to high lipid solubility, it easily enters the nerves and the 
blood vessels. 
Distribution:  
 It occurs in 2 phases - α phase, β phase. 
α phase      -    rapid uptake              –   highly perfused organ 
β phase       -    slow redistribution   –  moderately perfused organ 
Metabolism:  
It occurs in the liver by N-dealkylation, amide hydrolysis and conjugation 
into pipecolyloxlidine. 
Excretion:         
5% of Bupivacaine excreted unchanged in kidney   
PHARMACOLOGICAL EFFECT: 
Local  - it blocks the nerve conduction. 
Regional - touch, pain, temperature, motor, Vascular tone will   be lost in 
that region 
Systemic effect - cardio vascular and CNS toxicity 
ROUTES OF ADMINISTRATION: 
1. Sub arachnoid space. 
2. Epidural space. 
3. Peripheral nerves. 
4. Local infiltration. 
5. Skin surface 
RECOMMENDED MAXIMUM DOSE:   
          2-3mg/kg 
TYPE OF ANAESTHESIA AND CONCENTRATION: 
1. Spinal anesthesia          - 0.5% 
2. Epidural anesthesia      - 0.25% - 0.75% 
3. Peripheral nerve block   - 0.25% - 0.5% 
4. Infiltration                      - 0.25% - 0.5% 
 
TOXICITY: 
Bupivacaine causes systemic toxicity whenever the plasma concentration 
exceeds to exert the cardiovascular, central nervous system side effect.    
Cardio Vascular toxicity:   
Bupivacaine blocks the cardiac sodium channel and decreases the 
myocardial automaticity and decreases rapid depolarisation phase to produce 
prolonged myocardial depression.  So intravascular injection causes hypotension, 
AV block, and arrhythmias like ventricular fibrillation. 
CNS toxicity:  
When compared to cardiovascular system, central nervous system is more 
vulnerable to Bupivacaine toxicity. Initial symptoms of CNS toxicity are circum 
oral numbness, paresthesia, dizziness, blurring of vision, followed by restlessness, 
agitation, confusion followed by generalized tonic clonic seizure. 
TREATMENT: 
Treatment includes immediate resuscitation measures, oxygenation, 
ventilation, airway care, circulatory support. Inj.Thiopentone 1-2 mg/kg to 
terminate seizure. Intralipid 20% 1.5 ml/kg followed by 0.25ml/kg/min infusion for 
next 10 hours, Bretylium and Amiodarone can be given for resistant ventricular 
tachycardia. 
CONTRAINDICATIONS: 
                       Hyper sensitivity to local anaesthetic agent. 
                       Intravenous regional anaesthesia 
 
 
 
 
 
 
 
 PHARMACOLOGY OF ROPIVACAINE 
ROPIVACAINE: 
                                  
 
                    Ropivacaine is a amide group of local anaesthetics first 
synthesized in 1957 which have a structure of 1-propyl,2,6-
pipecoloxylidide. It is available as S- enantiomer. 
PHYSIO CHEMICAL PROPERTIES: 
1.  Molecular weight    -   274 
2.  pKa                          -  8.1 
3. Lipid solubility                   -  less 
4. Protein binding capacity     -  94 
5. Onset                                   -  moderate 
6. Duration                              -  
7.Elimination t1/2                    -  less than bupivacine.  
 
MECHANISM OF ACTION: 
                           Ropivacaine acts by blocking the voltage gated sodium 
channel by binding with the  α subunit of sodium channel from inside 
the cell.  So it prevent the rate of raise and magnitude of action potential. 
PHARMACO KINETICS: 
ABSORPTION: 
                       Absorption of ropivacaine from the site of deposit is 
influenced by site, dose , concentration and addition of adrenaline. Apart 
from this, age , cardiac function , hepatic functions also determine the 
absorption. 
Distribution :  
                  Similar to Bupivacaine, it has dual phase distribution in 
which Ropivacaine initially distributed into highly perfused organs like 
Brain and heart followed by least perfused organ like skin and muscle. 
Metabolism : 
                   Ropivacaine is metabolized in the liver by aromatic 
hydroxylation and N- dealkylation by liver microsomal enzymes.The 
metabolite was 2,6 pipecoloxylidide and 3- hydroxyl ropivacaine. 
Among the amide group Bupivacaine and Ropvaciane under go slowest 
metabolism. 
Excretion : 
                 Ropivacaine gets excreted in urine as 1% as 
unchanged.Clearance of Ropivacaine is higher and elimination half life 
is shorter when compared with Bupivacaine. So when compared with 
Bupivacaine, Ropivacaine is least toxic and short duration. 
 
PHARMACOLOGICAL PROPERTIES: 
                        Local                       -     it blocks the nerve conduction. 
                         Regional       -   touch, pain, temperature, motor,   
vascular tone will be lost in the  region. Sensory block is more than 
motor block with Ropivacaine 
                       Systemic effect       -  cardio vascular and Cns toxicity 
 
CLINICAL USES : 
                    1. Sub arachnoid block         -  0.75%  
                     2. Epidural                               -   0.5 to 1% 
                     3. peripheral nerve block         -   0.5 to 1% 
                     4. Infiltration                            -   0.2 to 0.5% 
RECOMMENDED MAXIMUM DOSE: 
                                2-3 mg / kg    
TOXICITY : 
                     Toxic profile of Ropivacaine is lower than Bupivacaine.  
 
 
 Cns toxicity : 
                         Peri oral numbness , dizziness , tinnitus , blurring of vision , finally  
convulsions may occur. 
Cardio  vascular Toxicity : 
                       Accidental intra vascular injection may causes Hypo tension , Brady  
cardia ,arrhythmia like ventricular fibrillation, ventricular tachycardia, heart block,   
Cardiac arrest . 
TREATMENT OF TOXICITY : 
1. Maintanence of Airway , Breathing , Circulation 
2. Treating the convulsion with Inj, Thio pentone , Midazolam. 
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ROPIVACAINE: 
 
 
 
 
 
 
 
ROPIVACAINE STRUCTURE 
 
Ropivacaine is an amide group of local anaesthetics5 first synthesized in 
1957 which have a structure of 1-propyl,2,6-pipecoloxylidide. It is available as S- 
enantiomer. 
 
 
 
                           
PHYSIO CHEMICAL PROPERTIES: 
1.  Molecular weight - 274 
2.  pKa   - 8.1 
3. Lipid solubility  - less 
4. Protein binding capacity- 94 
5. Onset   - moderate 
6. Duration   - 200 – 360 min 
MECHANISM OF ACTION: 
  Ropivacaine acts by blocking the voltage gated sodium channel by binding 
with  the α subunit of sodium channel from inside the cell.  So it prevents the rate 
of  rise and magnitude of action potential 
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PHARMACO KINETICS: 
ABSORPTION: 
Absorption of Ropivacaine from the site of deposit is influenced by site, 
dose, concentration and addition of Adrenaline. Apart from this, age, cardiac 
function, hepatic functions also determine the absorption. 
Distribution:  
Similar to Bupivacaine, it has dual phase distribution in which Ropivacaine 
initially distributed into highly perfused organs like Brain and heart followed by 
least perfused organ like skin and muscle. 
Metabolism: 
Ropivacaine is metabolized in the liver by aromatic hydroxylation and N- 
dealkylation by liver microsomal enzymes. The metabolite was 2,6 
pipecoloxylidide and 3- hydroxyl Ropivacaine. Among the amide group 
Bupivacaine and Ropivacaine undergo slowest metabolism. 
Excretion: 
Ropivacaine gets excreted in urine as 1% as unchanged. Clearance of 
Ropivacaine is higher and elimination half life is shorter when compared with 
Bupivacaine. So when compared with Bupivacaine, Ropivacaine is least toxic and 
short duration of action. 
PHARMACOLOGICAL PROPERTIES: 
Local  -     it blocks the nerve conduction. 
Regional - touch, pain, temperature, motor,   vascular    tone will be lost in 
the   region. Sensory block is more than motor block with 
Ropivacaine 
Systemic effect - cardio vascular and CNS toxicity 
CLINICAL USES: 
1. Sub arachnoid block - 0.75%                   
2. Epidural    -    0.5 to 1%                    
3. Peripheral nerve block - 0.5 to 1%                    
4. Infiltration  - 0.2 to 0.5% 
RECOMMENDED MAXIMUM DOSE: 
          2-3 mg / kg    
TOXICITY: 
Toxic profile of Ropivacaine is lower than Bupivacaine.  
CNS toxicity: 
Peri oral numbness, dizziness, tinnitus, blurring of vision, finally  
convulsions may occur. 
Cardio vascular Toxicity: 
Accidental intra vascular injection may causes Hypotension, arrhythmias 
like bradycardia, ventricular fibrillation, ventricular tachycardia, heart block and 
even cardiac arrest. 
TREATMENT OF TOXICITY: 
Treatment includes immediate resuscitation measures, oxygenation, 
ventilation, airway care, circulatory support. Inj. Thiopentone 1-2 mg/kg to 
terminate seizure, Intralipid 20% 1.5 ml/kg followed by 0.25ml/kg/min infusion for 
next 10 hours, Bretylium and Amiodarone can be given, if necessary.               
REVIEW OF LITERATURE 
1. Andrei Goldstein and Patrik Grimault etal6 compared the effects of 
intraperitoneal local anesthetic instillation for reducing the post operative pain and 
morphine consumption, which was assessed while the patient wakes up and  on the 
first post operative day, after laparoscopic gynecological surgeries 
Totally 180 patients were taken in their study and were randomly divided 
into 3 groups. Group B received 20ml 0f 0.5% Bupivacaine with 
1:200,000 Adrenaline, group R received 20ml of  0.75% Ropivacaine. They used 
numerical pain scale for pain assessment and four point scale for evaluating  
postoperative nausea and vomiting.  Inj.Morphine i.v was given as rescue analgesia 
whenever the numerical scale was >4 and further dose of subcutaneous morphine 
was given to keep the VAS  <4. 
There was a statistically significant reduction in the post-operative pain in 
both Ropivacaine and Bupivacaine group when compared with saline group. Total 
Morphine consumption in 24 hrs postoperative period in group B was 3.08mg 
±5.12(mean ± 2 SD), group R was 0.69mg ± 1.58, group S was 12.93mg ±9.30. 
Morphine consumption at wake up in group B was 0.92mg ± 2.27, group R was 
0.25 ± 1.89, group S was 4.18 ± 3.98. There was a significant reduction in post 
operative nausea and vomiting in both groups compared with saline group. 
2. H.kang,B.Gkim et al6 studied about the effectiveness of intra peritoneal 
instillation of Ropivacaine in laparoscopic appendicectomy. It was a randomized 
double blinded prospective study in which totally 63 patients were allocated into 2 
groups. group C received normal saline and group I received 2mg/kg Ropivacaine 
intra peritoneally after creating the pneumoperitoneum.  
VAS score, total Fentanyl requirement, frequency of pushing the button in 
PCA noted. 
There was a considerable reduction in pain score in group I compared with 
group C (p<0.005) . Total amount of Fentanyl consumed in the study in control 
group was 420µg compared with Ropivacaine group which was about 300µg.  
Frequency of   pushing the button in PCA was lower in Ropivacaine group 
compared to control group. There was no significant difference in vomiting 
incidence and duration of hospital stay between the two groups. No complication 
was noted between the groups. (The journal of international medical research 2010 
,38,821-832) 
 
3. Alexander et al7 have conducted a meta analysis about the efficacy of 
intraperitoneal instillation of local anaesthetics.  
 They have taken totally 24 various randomized control studies to analyse. 
Their analysis have included the studies which used  Bupivacaine, 
Levobupivacaine, Ropivacaine, Lignocaine, Bupivacaine with Adrenaline for intra 
peritoneal instillation. They analyzed the effect of local anaesthetics on the VAS 
score(0-100mm) /verbal pain score  
(0-10) /additional dose of analgesic requirement /frequency of analgesic 
requirements.  
Among them, 12 studies showed a statistically significant pain relief during 
the first 4 hours with weighted mean difference VAS of 9mm with 95% confidence 
interval (-13 to 15 mm). Weighted mean difference VAS measured before the 
surgical dissection was 6mm (95% confidence interval -10mm to -2mm) and after 
the surgical dissection was 13mm (95% confidence interval -19mm to -8mm).  
There was no significant adverse effect noted in any trials.(Anaesthesia Analgesia 
September 2006 vol 102,682-688) 
4. N.Malhotra et al8 studied about the effect of intraperitoneal Bupivacaine for 
post operative pain relief after gynecological surgeries. 
They have taken the patients, who have undergone Laparoscopic 
gynecological surgery under ASA I,II. They have divided the patients into 2 
groups. 50mg of 0.125% Bupivacaine was given intraperitoneally to Bupivacaine 
group and 30ml of saline was given intraperitoneally to saline group.  Post 
operative VAS score, time and dose of analgesic requirements were noted.  
VAS score was significantly less in Bupivacaine group(mean VAS=2) when 
compared to saline group (mean VAS 6,4) at 2nd hour and 4th hour with p 
value(<0.0001)  but there was no difference  after 6th hour and 8th hour with mean 
VAS 3,3 and 4,5 in both group at 6th hour and 8th hour. There was a significant 
difference in analgesic requirement between 2 groups with p value 0.006.There 
was no significant difference in nausea, vomiting,  shoulder tip pain between 2 
groups.(The Internet Journal of Gynecology and Obstetrics. 2006 Volume 5) 
5. J. W. Szem,   L. Hydo et al9 conducted a study about the effect       of 
intraperitoneal instillation of Bupivacaine for controlling the post operative  pain 
after laparoscopic cholecystectomy. There were totally 55 patients for evaluation. 
Among the 55 patients 26 were received 0.1% Bupivacaine as 100ml irrigation 
solution over the hepato diaphragmatic surface before the dissection. 29 patients 
received saline intraperitoneally in the same manner. 
Duration of post operative pain relief, post operative analgesic usage, 
incidence of post operative nausea, vomiting noted.  
There was a significant reduction in post operative pain in Bupivacaine 
group when compared with saline group  with p value <0.005.There was no 
reduction in analgesic requirement, post operative nausea ,vomiting or pain at the 
shoulder tip.(Journal of Surgical Endoscopy January 1996, Volume 10, Issue 1) 
6. Muhammad Riswan khan et al10 conducted a study in 206 patients about the 
efficacy of intraperitoneal instillation of two different local anesthetics.   
All the 206 patients were randomly allocated into 2 groups of which group 
L received 10ml 0f 2% lignocaine and group B received 10 ml of 
0.5%Bupivacaine intraperitoneally.  
Abdominal pain was less in both Bupivacaine and the Lignocaine group 
with a P value <0.001 .When compared with lignocaine group(87%), little higher 
dose of opioid was needed for Bupivacaine(94%) group p=0.057. They found out 
that there was no significant difference in pain relief in between group L,B. 
(Journal of Surgical Research)  
7. CananKucuk et al11 in their study compared Placebo with Bupivacaine, 
Ropivacaine in two different doses in the prevention of post-operative pain after 
laparoscopic cholecystectomy.  
  Totally 80 patients were taken, and they randomly divided into 4 groups -  
group S, group R1, group R2, group M who received  saline, Ropivacaine 100mg- 
with Adrenaline 1:200,000, Ropivacaine  150 mg-with Adrenaline1:200,000, 
Bupivacaine 100 mg respectively inside the peritoneum after the end of the 
surgery. They used PCA pump for post-operative analgesic delivery. They 
compared the VAS score, 24 hour morphine requirement, sedation, hemodynamics, 
respiratory rate in the postoperative period over 24 hours.  
  There was a significant reduction in the VAS score in all 3 groups except 
saline group in 1,2,12 hours. Total dose of morphine consumed in saline group is 
significantly higher when compared with the other groups with p value<0.001 in 
all the 24 hours. With in the group, morphine consumption is significantly less in 
group R2. There was no significant difference in MAP, Heart rate, respiratory rate, 
sedation scale, complications in between all the 4 groups. (Surgery Today (2007) 
8.  Todorov G et al12 compared the effect of intraperitoneal Levo bupivacaine to 
relieve the pain after laparoscopic cholecystectomy. There were two groups studied 
of which one received inj. Levo Bupivacaine, another group received saline 
injection intraperitoneally after the dissection. Visual analogue scale and total need 
of analgesics was compared post operatively.  
There was a significant reduction in abdominal pain in Levo Bupivacaine 
when compared with the saline group at second hour (p=0.038), sixth hour after 
surgery (p=0.028).and Levo Bupivacaine group consumed less analgesia. 
(Khirurgiia (Sofiia). 
9. Kocamanoğlu et al 13. They and their colleagues studied about the use of 
intraperitoneal Bupivacaine and Ropivacaine to relieve the abdominal pain and 
shoulder pain after laparoscopic surgery. They have taken totally 55 patients of 
which 17 received 20ml of 0.5% Bupivacaine, 18 patients received 20 ml of 0.75% 
Ropivacaine intraperitoneally. Post operative pain was noted for 24 hours. They 
concluded the study with results in which shoulder pain were less in groups 
received Bupivacaine and Ropivacaine intraperitoneally. (PMID:16552651 
PubMed ) 
 
10. Artemisia et al 14 conducted a trial in 71 patients about the repeated instillation 
of local anesthetics (Levo Bupivacaine) intraperitoneally to relieve the pain after 
surgery.  
Totally 2 groups of which one group received 0.5% Bupivacaine intra 
peritoneally after the dissection and eight hours after surgery. Control group 
received saline in the same period. They compared the VAS score, opioid 
requirement in two groups. Levo Bupivacaine group showed less visual analogue 
scale when   compared with saline group. Total Fentanyl requirement was 
significantly less in the study group when compared with the saline group. 
 
11. Alkhamesi et al15 conducted a study about the intraperitoneal effect of local 
Anesthetics to decrease the pain after laparoscopy surgeries.  
 
              Total 80 patients were divided into 4 groups. Each group received 
aerosolized Bupivacaine, saline and local infiltration of Bupivacaine in bladder bed 
compared with control group .Pain score and the opioid requirement were 
compared which were significantly lower in Bupivacaine group compared with the 
other group (Pub med:17180268). 
 
12. Hernández  et al 16 They in their study added morphine with Bupivacaine and 
gave intraperitoneally to assess the efficacy of pain relief after laparoscopic 
cholecystectomy.  
 
Among the 90 patients 30 received 30ml of 0.25% Bupivacaine, 30 patients 
got 30ml of 0.25% Bupivacaine with 2mg morphine intraperitoneally, 30 patients 
were in control groups.  Pain score (VAS, VRS), total dose of Metamizol via PCA 
were noted.  
Results were analyzed. Except during the second hour there was no 
difference in the pain score in all the 3 groups. Metamizol consumption was 
significantly lower in both group 1,2(p<0.05). 
 
13.  Mraović B et al 17 compared totally 80 patients. They randomly divided them 
into 2 groups, Out of which one group received  
15ml 0f 0.5% 
Bupivacaine, both during the starting of the surgery and after the surgery. 
Second group received saline in the same manner.VAS scale  was compared at half 
an hour, 4, 8, 12, 24 hours post operatively. 
Pain score was lower in study group when compared with saline group. But 
this difference was upto 8 hours. Analgesic requirement were lower in study group. 
14.  Barczyński M et al18  Their study evaluated the optimum timing for 
instillation of local anesthetics intraperitoneally to give maximum analgesic effect.  
There were totally 4 groups. Out of which, one group received 2mg/kg 
Bupivacaine instilled before CO2 insufflation (A group), 2nd group received the 
same dose after insufflation (B).3rd (C),(D)4th group received saline in the same 
manner. Post operative VAS score, analgesic need, rate of analgesic requirement 
noted. Lower VAS scores were recorded in Bupivacaine group at 4th, 8th hour and 
not after that. Compared to B, C, D group, A had less shoulder tip pain, lower 
analgesic need, long latency of analgesic requirement were noted. Intraperitoneal 
instillation of local anaesthetic agent before CO2 insufflation was found to be more 
effective. 
15.  Dreher JK et al19 They conducted a study about the effect of intraperitoneal 
local anesthetic agent after the laparoscopic gynecological surgeries. They used 
Ropivacaine 200mg intraperitoneally after the end of the surgery and compared 
with saline.VAS score, total opioid requirement, post operative vomiting 
compared. 
Ropivacaine group  showed less VAS(0.97) during the second post operative 
hour when compared with the saline group(2.03) which was statistically significant 
(p<0.05).Total Fentanyl requirement was less in study group 40µ when compared 
with saline group 104 µ. Study group showed less(10%) nausea and vomiting 
compared with saline group(44%). (Aust N Z J Obstet Gynaecol. 2000 Nov). 
 
16. Ahmed BH et al20 they analyzed totally 200 patients in their study. 200 
patients were randomly allocated into 4 groups, group A-Control, group B received 
saline, group C received Bupivacaine, group D received Lignocaine 
intraperitoneally.VAS scale, VRS scale were compared between 4 groups. other 
parameters like post operative nausea vomiting, analgesic needs were compared. 
Results: Both groups C,D were showed better pain 
scale(VAS,VRS).Lignocaine showed better pain relief compared with Bupivacaine 
in their study. 
17. Bucciero M et al compared intraperitoneal nebulisation of ropivacaine with  
saline. They have taken totally 60 patients of which 30 received 20 ml of 0.5%  
bupivacaine intraperitoneally and 30 patients received saline intraperitoneally after 
the pneumoperitoneum. 
They have concluded the study in which there was no significant reduction 
in pain score in both groups. Patients who received Ropivacaine has less shoulder 
tip pain (p<0.001)and early ambulation compared with the control group. 
  
 
 
MATERIALS AND METHODS: 
This study is a prospective, randomized, comparative study for evaluating 
the efficacy of intraperitoneal instillation of Bupivacaine 0.5% vs Ropivacaine 
0.5% for post operative pain relief after elective laparoscopic abdominal surgeries.  
Institutional ethical committee approval was obtained. Totally 90 patients 
were selected. After getting the informed consent from the patients they were 
randomly allocated into 3 groups, group B group R, group S. 
 SELECTION OF CASES:     
All the 90 patients both male and females were between the age group 16-
70years who had been preoperatively assessed under ASA physical status I and II. 
They were posted for elective laparoscopic abdominal surgeries in the department 
of general surgery and  department of surgical gastroenterology in Rajiv Gandhi 
Government hospital. 
VENUE: 
General surgery and   Surgical Gastroenterology theatres. Rajiv Gandhi 
Government hospital, Chennai. 
STUDY DESIGN: 
The study was a Prospective, randomized, single blinded study in which the 
two groups, group B (Bupivacaine) and group R (Ropivacaine) were compared 
with the group C (control). 
INCLUSION CRITERIA: 
1. Patients of age 16 to 70 years. 
2.  ASA physical status I&II. 
3. Patients posted for elective laparoscopic abdominal surgeries. 
4.  Patients who had given informed written consent. 
EXCLUSION CRITERIA: 
1. Patients not satisfying above inclusion criteria. 
2. ASA PS III, IV&V. 
3.  Local anesthetics allergy. 
4.  Patients refusal. 
5.  Pregnancy. 
6.   Patients with CVS, respiratory, liver and renal diseases. 
7.   If any other surgeries combined with the laparoscopic surgery in the same 
sitting    like incisional hernia, umbilical hernia. 
STUDY GROUPS: 
• GROUP B –  Bupivacaine group - patients received  2mg/kg of                    
bodyweight 0.5%  Bupivacaine  intraperitoneally  
• GROUP R – Ropivacaine group- patients received 2mg/kg of bodyweight 
0.5% Ropivacaine intraperitoneally. 
• GROUP C – control  group–patient received 20 ml of 0.9%saline 
intraperitoneally 
 MATERIALS: 
• Intravenous set with iv fluid with 18G iv cannula 
• Laryngoscope, airway, bougie, appropriate size endo tracheal tube 
• Drugs- Thiopentone sodium, Glycopyrrolate, Fentanyl, Succinyl 
choline,Atracurium,Atropine,Adrenaline,Ephedrine,Ranitidine,Ondansetron,
Bupivacaine 0.5%,Ropivacaine 0.5%,saline 
• Monitors-NIBP, ECG, SPO2, temperature ,ETCO2 
• VAS chart 
 
 OUTCOMES MEASURED: 
Primary outcomes: 
1. Post operative pain relief  using visual analogue scale(0-100mm) 
2. Post operative total analgesic requirement 
3.  Duration of analgesia 
Secondary outcomes: 
1. Post operative nausea and vomiting 
2. Blood pressure (SBP, DBP, mean) 
CONDUCT OF STUDY: 
Institutional ethical committee clearance was obtained. Totally 90 patients 
who satisfied the inclusion criteria posted for elective laparoscopic intra abdominal 
surgeries were selected for the study. They were randomly allocated into 3 groups. 
Group B, R, S 
ANAESTHESIA: 
After getting the informed consent, height and weight were measured; 
patients were shifted into the theatre. Local anesthesia test dose was given. After 
confirming the absence of allergic reaction, monitors were connected (ECG, NIBP, 
PR, ETCO2 and SPO2) .Basal parameters were noted. 
Patients were premedicated with inj. Glycopyrrolate 0.04mg, pre oxygenated 
with 100% O2 for 3min with bag and mask. Induction was carried out with 
inj.Fentanyl 2mic/kg, inj. Thiopentone 5mg/kg and intubated with  an appropriate 
size endo tracheal tube after a loading dose of inj. Atracurium (0.5mg/kg), 
maintenance of anesthesia  was with N2O:O2 2:1,sevoflurane 1-2%,inj Atracurium 
0.1mg/kg .No extra dose of analgesia was given intra operatively   
SURGERY:  
All the surgeries were done by trained surgeons. After skin incision 11mm 
trocar is introduced via umbilical port, abdomen is inflated with CO2 1 lit/min with 
intra abdominal pressure kept around 12-14mmHg, in all patients.  
After the procedure gets over, abdomen was thoroughly washed to remove 
the blood clots and debris. Inj. Bupivacaine (preservative free) 0.5% 2mg/kg with 
10ml distilled water/ Inj. Ropivacaine (preservative free) 0.5% 2mg/kg with 10ml 
distilled water /30ML of normal saline is instilled intra peritoneally under vision.  
After the removal of trocar, CO2 gas was completely evacuated from   the   
abdomen.    Patients   were    kept in Trendelenberg position for 10minutes.If 
abdominal drain was present it was clamped.4ml of   2% Lignocaine was 
infiltrated into the skin. During the surgery ETCO 2 value was maintained between 
25 to 35 mmhg. 
After the   skin closure, adequate spontaneous ventilation   and 
neuromuscular recovery patients were reversed with inj. Neostigmine 40µ/kg and 
inj.Glycopyrrolate 0.4mg iv and extubated.  
POST OPERATIVE PERIOD: 
All the patients   were shifted to PACU for observation. Primary and 
secondary outcomes were measured. VAS Score at 0, 1, 2, 3, 4, 5, 6,10,12,24 hours 
were noted.  Inj. Fentanyl 1µ/kg i.v given as the rescue analgesia whenever the 
VAS   score  were more than 3.Total dose of Fentanyl required was noted in these 
periods. Time of the first rescue analgesic requirement was noted. Presence of 
complications was noted. 
 
 
  
STATISTICAL ANALYSISIS 
 
Statistical analysis were done with statistical package for social sciences 
(SPSS for windows, version 15) 
• Results are expressed as mean and standard deviation. 
• All qualitative variants were compared using Chi Square test and 
quantitative variants using students‘t’ test.  
• A ‘p’ value of less than 0.05 was considered significant.    
 
 
 
 
 
 
 
05
10
15
20
25
30
35
40
 
T
differen
between
 
 
 
 
 
control
otally 90 
ce in term
 the three 
Grou
contr
Ropiva
Bupiva
ropivacain
OBS
patients w
s of age
groups an
Tabl
p Nu
ol 
caine 
caine 
e bupiva
age in y
ERVATI
ere includ
, sex, hei
d shown in
e 1.Demo
mber 
30 
30 
30 
Figu
caine
ears
ON AND 
ed in our
ght, weigh
 Table 1 t
graphic p
Mean 
35.30 
29.37 
31.80 
 
re 1 AGE
RESULT
 study.  T
t, BMI a
o 5.           
rofile: Ag
SD 
11.26
8.00 
10.91
 
age in 
S 
here was 
nd durati
         
e 
P val
0.08
N.S
years
no signifi
on of sur
ue 
1 
 
cant 
gery 
  
 
 
 
    
 
 
 
0
5
10
15
20
25
30
35
con
Grou
contro
Ropivaca
Bupivaca
trol ro
Tab
p Num
l 3
ine 3
ine 3
pivacaine
le 2.Demo
ber M
0 
0 
0 
Figu
bupivacai
graphic p
ale 
16 
9 
12 
 
re 2 SEX
ne
rofile: Sex
female 
14 
21 
18 
 
tota
fem
tota
 
P valu
0.18
N.S
l 
ales
l males
e 
3 
 
  
 
                Table 3 : Demographic profile : Weight 
Group Number Mean SD P value 
control 30 60.57 8.67 0.245  
N.S         Ropivacaine 30 59.60 11.16 
Bupivacaine 30 56.27 8.45 
 
 
Table 4 Demographic profile: Height 
Group Number Mean SD P value 
control 30 156.80 9.13 
0.269 
N.S 
Ropivacaine 30 154.87 8.13 
Bupivacaine 30 152.97 9.23 
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Table: 6 DURATION OF SURGERY 
Group Number Mean SD P value 
control 30 85 24.49 
0.086 
Not 
significant 
Ropivacaine 30 71.67 37.77 
Bupivacaine 30 69.17 23.67 
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Table  7    : VAS SCORE 
VAS 
MEAN CONTROL ROPIVACAINE BUPIVACAINE 
P 
value 
0 HR 5.00 3.57 3.40 0.000*
1 HR 3.47 2.80 2.53 0.000*
2 HR 3.50 2.70 2.67 0.004*
3 HR 3.83 2.90 2.73 0.000*
4 HR 4.07 3.17 2.77 0.000*
5HR 3.57 3.50 2.73 0.002*
6 HR 3.57 3.10 3.27 0.401 
10 HR 3.57 3.50 3.70 0.766 
12 HR 3.83 3.23 3.20 0.133 
24 HR 3.03 3.13 2.87 0.563 
100
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• In control group rescue analgesia were given in 12.90+/- 13.38 minutes 
when compared with Bupivacaine, where it was 355 ± 25.24 minutes and  
for Ropivacaine, it was 264.33 ± 144.79 minutes postoperatively, which was 
found to be highly significant(p=0.000).  This showed that Bupivacaine 
provided adequate analgesia for the first 6 hours when compared to 
Ropivacaine, which provided adequate analgesia for about 4 hours 24 
minutes.   
Figure 8 TOTAL ANALGESIC DOSE 
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Ropivacaine(fentanyl 92.33± 34.81 µ gm ) groups, the difference was found 
to be statistically insignificant(p=0.126). 
 
Table 9 TOTAL RESCUE ANALGESIC DOSE REQUIREMENT 
Group Number Mean SD P value 
Control 30 184 45.38 
0.000 
significant 
Ropivacaine 30 92.33 34.81 
Bupivacaine 30 74.00 25.24 
 
 
Table 10,11 HEMODYNAMIC PARAMETERS 
Table  10 :Mean arterial pressure 
The Mean Arterial Pressure was monitored postoperatively in all the groups 
and were analysed statistically.  The hemodynamics in all the groups was stable 
and was found to be statistically insignificant. 
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Basal 89.50 11.39 85.60 13.49 83.80 10.54  
2 hour 85.13 10.01 86.10 13.83 86.23 9.97  
3 hour 84.70 10.04 82.93 9.28 89.10 11.67  
4 hour 87.77 11.97 82.07 10.81 89.03 9.83 <0.05 
6 hour 88.77 11.19 85.20 11.84 85.33 9.43  
7 hour 85.07 11.83 81.33 8.55 86.90 8.24  
8 hour 87.17 15.14 81.20 10.41 89.40 7.21  
10 hour 84.70 13.00 80.87 14.59 90.53 8.93  
12 hour 87.03 12.73 81.90 12.49 91.03 11.20  
 
 
 
The pulse rate was also monitored postoperatively and were compared  
among the groups.  Though there were changes in the heart rate in all the  groups, 
they were comparable and was shown to be statistically insignificant  between the 
groups. 
Table 12: NAUSEA AND VOMITING 
•     There was a significant reduction in nausea and vomiting in the patients who 
received Bupivacaine or Ropivacaine intraperitoneally. 
•     Among the 90 patients, 7 patients from the control group had postoperative 
vomiting, which was found to be statistically significant (p = 0.012), when 
compared to Bupivacaine and Ropivacaine group, where the incidence of 
Postoperative vomiting was less(1 patient in each group)  
• The reason for this high incidence of PONV(Post Operative Nausea Vomiting) 
in the control group, might be due to the higher requirement of rescue analgesia 
in the form of opioids(Fentanyl), which is one among the risk factors for PONV 
under Apfel’s scoring(  female, non-smokers, opioid use intraoperatively, 
History of PONV/ motion sickness ) 
 
Table 12: NAUSEA AND VOMITING 
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DISCUSSION: 
 Laparoscopic techniques have gained popularity in the recent years, mainly 
because of the fact that it involves small incision, short hospital stay and early 
ambulation.  Though it has got various advantages on its own, the peritoneal 
stretching due to the insufflation of gases results in excessive pain postoperatively.  
Various modes of providing analgesia were tried.  The techniques that can be used 
for providing pain relief in Laparoscopic surgeries include surgery under 
subarachanoid block, parentral opioids and NSAIDs, Instillation of local 
anaesthetics intraperitoneally, etc.,  
 Surgery under subarachanoid block provided adequate analgesia both 
intraoperatively and postoperatively, but the level of sensory block required 
intraoperatively was very high (Thoracic level 4), which resulted in higher 
hemodynamic instability.  The time for ambulation postoperatively was also 
extended.    
 The use of parenteral opioids provided adequate analgesia, but the amount of 
drug required was higher, resulting in various complications like respiratory 
depression, postoperative nausea vomiting, constipation, pruritis which needs 
adequate postoperative monitoring thereby increasing the hospital stay. 
 Instillation of local anaesthetic solution intraperitoneally, as a mode of 
providing postoperative analgesia, has been studied extensively.  It has the added 
advantage of early ambulation, reduced incidence of postoperative nausea 
vomiting and reduces the use of parentral opioids and NSAIDs. 
 This study was done to compare the analgesic efficacy of Bupivacaine and 
Ropivacaine, which were instilled intraperitoneally, with a control group. 
 All the groups were comparable with respect to the demographic datas 
including Age, Sex, Height, Weight, BMI etc… They were also comparable in 
terms of the duration of surgery.   
  In our study mean duration of pain relief in  Bupivacaine group  and Ropivacaine  
group  was 355 ± 180.72 min and 264.33 ± 33 min respectively .In Saline group it 
was about 12.90+/- 13.38  minutes. 
 
ANALGESIC REQUIREMENT: 
In our study it was found that the total dose of opioid required in the post 
operative period was significantly less in both Bupivacaine and Ropivacaine group, 
when compared to the control group. Out of these two groups Bupivacaine group 
needed less Fentanyl 74 ± 25.24µg, when compared with Ropivacaine group which 
needed 92.33 ± 34.81µg, though the difference was found to be statistically 
insignificant(p>0.05). But the saline group needed double the dose 184µ ± 
45.38µg, which was statistically significant (p<0.05).  
  This difference in the Fentanyl requirement closely correlates with the study 
done by  Tae Han kim et al21 , where the total dose of Fentanyl consumed in 
Ropivacaine group  was 367 ± 85.88 µg over 48 hour via  PCA when compared  to 
535 ± 100.29µg in control group. This was statistically significant with a p value of 
<0.001. 
 Rajini gupta et al22 also demonstrated the same in which saline vs 
Bupivacaine vs Bupivacaine and Fentanyl were compared. Total diclofenac 
consumption was about 65 ± 15mg in Bupivacaine with Fentanyl compared with 
saline 128 ± 25mg.  
    Palmes et al23, also supports our study in which they used 0.5% lignocaine 
before the pneumo peritoneum vs 0.5% lignocaine after the surgery. Analgesic 
piritramide consumption in both groups were 11.1 vs 18.5 with p=0.002 when 
compared to the control group.  
                 
Boddy AP24,Mehta also concur our study.  
Karaaslan25 et al demonstrated less analgesic requirements (diclofenac) in the 
patients, who received 0.5% Bupivacaine 23.4± 35.9 mg compared with placebo 
(saline) group 70.0 +/- 59.9 mg.   
Hernandez et al26   used Metamizol as a rescue analgesia for post laparoscopic 
pain. In the patients who received Bupivacaine with morphine intra peritoneally 
consumed less Metamizol 2025 ± 1044 mg when compared with control 4925 ± 
1238mg. 
 
PAIN SCORE: 
In our study the median VAS score for Bupivacaine group was 2.82 over 24 
hours and in Ropivacaine group median VAS score was 3.15, which was found to 
be statistically significant(p<0.05) 
 
Malhotra et al in their study compared 0.125% bupivacaine with saline 
intraperitoneally. Mean VAS score at 2nd and 4th hour was 2,2 for Bupivacaine and 
6,4 for saline group, which was similar to our study.   
 
Mraovic17 and coworkers used 0.5% of Bupivacine intra peritoneally after CO2 
insufflation and after the dissection. They provided excellent analgesia upto 8 
hours with less analgesic consumption. Our results were similar to this study with 
Bupivacaine instillation after the dissection. 
Gupta A28  with his colleagues compared Ropivacaine  0.5%  with saline injected  
intra peritoneally near the gall bladder fossa. They kept  the catheter at the gall 
bladder bed through which 20 ml Ropivacaine was given after the dissection. 
When compared with saline group, in  patients  who had Ropivacaine in the post 
operative period, had good VAS and better pain relief  upto  4th  post operative 
hour.  In our study we used  Ropivacaine 0.5%  as a single shot technique provided 
pain relief for  260 minutes which strongly correlates with this study. 
Rajni Gupta et al29  compared Bupivacine vs Bupivacaine with Fentanyl and 
saline. Patients who have received Bupivacaine with Fentanyl, showed VAS score 
40.3 ± 7.4 compared with saline 50.1± 78. They proved that there was a narrow 
margin between the VAS score of both the groups. This study strongly supports 
our study, in which the median VAS score for Bupivacaine group was 2.82 over 24 
hours and in Ropivacaine group median VAS score was 3.15 . 
Andrei et al30 and colleagues compared 100 mg of Bupivacaine with 150mg of 
Ropivacaine for intraperitoneal instillation. They were given 50mg higher dose of 
ropivacine compared with Bupivacaine since Ropivacaine is less cardiotoxic. In 
both groups pain score and subcutaneous morphine consumption and vomiting 
were low, which was similar to our study. Due to higher dose of ropivacaine, 
morphine consumption was significantly less in Ropivacine  group compared to 
bupivacaine group.  Similar to our study, there was no significant variation in 
hemodynamics. 
Hernándes et al 26 and his coworkers added an adjuvant with local anaesthetics to 
study the efficacy. They compared 0.25% Bupivacaine  with 2mg intra peritoneal 
morphine and 0.25% Bupivacaine with 2mg i.v morphine. Rescue analgesic 
(Metamizol) requirement were lower in Bupivacaine with intraperitoneal morphine 
group(2025± 1044mg) when compared with Bupivacaine with i.v morphine 
(4125± 1276mg) during the first 6hours.So adding an adjuvant with lesser 
concentration of local anaesthetics will provide analgesia similar to the higher 
concentration of anaesthetics. 
 
 
DURATION OF ANALGESIA: 
In our study intraperitoneal instillation of Bupivacaine or Ropivacaine at the 
end of the surgery provided analgesia for 355 ± 180.72 min and 264.33 ± 33 min 
when compared with saline group which was about 13 ± 26.93 minutes, which was 
found to be statistically significant (p) 
 
Chou YJ 31and coworkers used 0.5% Bupivacaine (50 mg) after the dissection, 
compared with the group which has received both before the pneumo peritoneum 
and after the dissection (100mg) group. In the patients who received Bupivacaine 
both before and after dissection had less pain when compared with placebo. But 
the duration of analgesia was up to 8hours, which also supports our study. 
 
Shabir Ahmad et al32 compared intra peritoneal Bupivacaine with intravenous 
tramadol for post operative pain  relief  in which the mean VAS in Bupivacaine 
group was  at 1st ,2nd ,3rd , 4th  and 5th  hrs were 3.50, 2.80, 2, 1,30 and 0.06 
respectively, but in tramadol group  VAS was 2.20 ,1.83 ,1.40 ,1.07 and 0.7. Pain 
relief was better with i.v tramadol group than intraperitoneal group. 
 
Narchi et al33 compared intraperitoneal bupivacine with Ropivacaine and 
concluded that both were more effective in controlling the post operative pain with 
less analgesic requirements.  The results were similar to our results 
 Ljiljana et al34  used 0.25% Bupivacaine vs  0.25% Bupivacaine+ 2mg Morphine 
.They have concluded that the post operative pain relief in intraperitoneal 
Bupivacaine with morphine  was about 6 hours, which was similar to our study.  
Chundrigar et al35 and his coworkers used 0.25% of Bupivacaine intraperitoneally 
and concluded VAS score was good with less analgesic requirement. 
Szem et al 36also showed the same duration of pain relief like our study. They used 
0.1% Bupivacaine intraperitoneally. Pain relief was modest which lasted for 6 
hours. 
 
 
 
VOMITING:  
In our study among the Bupivacaine, Ropivacaine group incidence of 
vomiting was 2.22% when compared with control group 7.77% which was 
clinically significant with p=0.012. 
Andrei et al30 in their study compared the post operative vomiting in the patients 
who received Bupivacaine, Ropivacaine intraperitoneally.  They used 4 point scale 
for evaluation. Compared with control group ( 1.11) bupvacaine (0.41) and 
Ropivacaine (0.48) group experienced less vomiting. Antiemetic treatment was 
needed only 10%  Bupivacaine group and 15% in Ropivacaine group compared 
with saline group which was about 43%. 
HEMODYNAMICS: 
In our study there was no significant hemodynamic changes noted. 
PR,BP,SPO2 were maintained within 20% of the normal limit through out the 
study. 
 
Canan kucuk et al11, Kang et al37, and coworker showed there was no significant 
change in the hemodynamics during the study which was similar to our study. 
COMPLICATIONS: 
In our study no significant complications were noted like seizure and allergic 
reaction. Ljiljana  Et al34 ,Rajni gupta et al29, Andrei et al  also demonstrated that 
their study was without any complications. 
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SUMMARY 
From this prospective, randomised, comparative, double blinded, case 
control study which evaluated the effectiveness of intraperitoneal instillation of 
Bupivacaine compared with Ropivacaine for post operative pain relief after 
laparoscopic abdominal surgeries.  
The following observations were noted… 
1. The demographic profiles like Age, Sex, BMI, ASA status were comparable 
in all the groups. 
2. Duration of post operative pain relief after intraperitoneal instillation of  
Bupivacaine was longer than Ropivacaine. 
3. The VAS score was lower in Bupivacaine and Ropivacaine group when 
compared with saline group over the first 6 hours postoperatively. 
4. Total Fentanyl requirement was lower in Bupivacaine and Ropivacaine 
group  compared with saline group. 
5. Post operative nausea and vomiting was significantly lower in both 
Ropivacaine and Bupivacaine group when compared to the control group. 
6. Duration of surgery, hemodynamic parameters and complications were 
comparable in all groups 
 
 CONCLUSION  
We conclude that intraperitoneal instillation of local anaesthetic drug is 
useful for post operative pain relief for patients undergoing laparoscopic surgeries 
and 0.5% Bupivacaine is a better analgesic when compared to intraperitoneal 
instillation of 0.5% Ropivacaine, with well maintained hemodynamics 
postoperatively.                         
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Researcher name :  Dr. Sujatha, M.D (Anaesthesia) 
Participant name : 
 
Research topic: 
Comparison of Intraperitoneal instillation of Bupivacaine, Ropivacaine and 
saline for postoperative pain relief in laproscopic abdominal surgeries. 
 
Purpose of the study: 
During laparoscopic abdominal surgeries insufflation of co2 gas causes 
stretching of the peritoneum causes pain in the abdomen 
postoperatively.Intraperitoneal instillation of Bupivacaine or Ropivacaine relieve 
this pain in the postoperative period. 
 
Nature of the study: 
                                Participant who are all participating in the above mentioned 
study will get Bupivacaine or Ropivacaine or saline intraperitoneally via 
laparoscopy port after the procedure get over and will comparing the post operative 
pain relief of all the three. 
 
Uses: 
Post operative pain in the patient receiving Bupivacaine or Ropivacaine 
intraperitoneally will be very less than whom those not receiving and pulse rate 
and bp will be stable and post operative vomiting will be less. 
 
  
Complications: 
During the study patient will not get any problem. 
If you don’t want to participate in this study then you will get the usual pain 
relief in the post operatively. 
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s.no Name age sex weight height BMI diagnosis surgery group duration
Kg cm min basal 0 min 10 min 20 min  30 min 1 hr 2 hr 3 hr 4 hr 5 hr 6 hr 7 hr 8 hr 10 hr 12 hours basal 0 min 10 min 20 min  30 min 1 hr 2 hr 3 hr 4 hr 5 hr 6 hr 7 hr 8 hr 10 hr 12 hours basal 0 min 10 min
1 susheela 44 f 50 148 22.83 sub ac cholecystitis  lap cholecystectomy bupivacaine 90 92 89 93 86 82 91 91 83 82 76 78 76 102 82 83 123 130 134 122 126 122 122 122 126 136 132 124 144 126 124 70 82 87
2 sivagami 47 f 55 151 24.12 sub ac appendicitis lap appendicectomy bupivacaine 100 82 79 77 78 78 76 77 74 87 77 74 77 76 77 74 100 98 98 98 98 96 95 94 120 110 100 96 98 100 102 69 67 68
3 mashek  18 m 60 151 26.31 sub ac appendicitis lap appendicectomy bupivacaine 80 98 84 82 85 86 88 79 84 86 99 83 88 86 82 83 118 124 108 114 124 130 114 124 113 139 130 114 128 125 123 86 86 62
4 krishnaveni 46 f 52 146 24.39 cal cholecystitis lap cholecystectomy bupivacaine 80 86 87 80 71 79 78 78 72 77 97 100 108 88 87 86 137 139 138 130 140 142 138 139 136 132 152 139 142 136 136 70 72 76
5 padmavathi 26 f 55 156 22.6 cal cholecystitis lap cholecystectomy bupivacaine 40 96 97 98 98 88 87 90 88 92 115 88 87 86 82 88 133 135 133 146 142 132 132 136 132 162 132 132 136 133 132 83 96 91
6 deivanai 30 f 60 150 26.67 ovarian cyst lap ovarian cystectomybupivacaine 55 100 96 91 92 87 88 89 78 112 99 89 88 88 88 78 134 114 113 112 122 122 112 126 145 128 112 118 117 118 119 83 82 86
7 nandhini 20 f 35 134 19.49 sub ac appendicitis lap appendicectomy bupivacaine 80 80 82 80 80 70 72 73 72 66 66 62 62 66 66 110 108 107 116 115 100 102 110 100 102 104 103 110 108 107 129 82 81 80
8 ramya 26 f 53 155 22.06 cal cholecystitis lap cholecystectomy bupivacaine 60 90 92 88 77 76 76 73 92 73 75 72 71 72 77 98 119 145 124 122 115 109 110 129 116 100 110 122 112 112 116 91 65 78
9 kumar 45 m 60 155 24.97 Tb abdomen diag laproscopy bupivacaine 50 102 98 99 96 93 94 92 98 92 92 88 92 94 92 110 122 131 133 120 121 121 110 108 100 106 110 121 120 110 130 90 93 92
10 vahitha 20 f 43 150 19.11 sub ac appendicitis lap appendicectomy bupivacaine 80 102 110 108 110 107 102 102 99 98 97 98 94 119 102 98 115 136 137 132 116 117 116 117 98 100 106 107 129 120 116 74 77 72
11 saravanan 25 m 60 165 22.04 sub ac appendicitis lap appendicectomy bupivacaine 70 89 88 86 92 87 87 87 84 82 90 88 78 97 86 87 134 135 144 131 127 123 121 121 120 122 126 124 148 121 124 85 84 84
12 malliga 53 f 53 145 25.21 sub ac appendicitis lap appendicectomy bupivacaine 40 88 102 104 99 98 88 83 82 84 110 88 86 82 78 87 140 142 144 142 131 110 121 122 123 148 122 122 132 112 113 88 92 94
13 valarmathi 35 f 62 142 30.75 sub ac appendicitis lap appendicectomy bupivacaine 60 88 76 78 79 80 82 88 87 88 76 99 76 77 78 78 130 130 132 131 130 126 127 122 124 121 149 122 127 124 121 70 72 76
14 ramani 30 f 65 144 31.35 cal cholecystitis lap cholecystectomy bupivacaine 120 88 92 96 92 94 88 99 88 78 72 74 77 72 74 78 127 130 132 140 132 131 156 123 122 121 118 121 128 124 121 77 89 88
15 sathish kumar 19 m 62 170 21.45 sub ac appendicitis lap appendicectomy bupivacaine 60 77 98 88 87 89 86 78 78 86 80 72 99 80 76 77 132 137 122 125 128 117 115 116 115 118 145 117 140 116 124 69 72 66
16 jamuna 35 f 60 150 26.67 ovarian cyst lap ovarian cystectomybupivacaine 120 80 78 88 86 88 91 87 88 86 102 88 78 78 70 78 120 138 128 128 128 100 102 110 108 118 102 104 105 108 108 98 66 76
17 uthandi 63 m 60 165 22.04 cal cholecystitis lap cholecystectomy bupivacaine 90 75 78 80 82 84 88 78 87 110 80 82 88 83 82 87 140 156 142 143 148 132 134 135 160 134 135 135 135 146 132 90 98 98
18 savithri 36 f 70 155 29.14 cal cholecystitis lap cholecystectomy bupivacaine 50 102 98 99 96 93 94 92 98 92 92 88 92 94 92 110 122 131 133 120 121 121 110 108 100 106 110 121 120 110 130 90 93 92
19 roja malar 28 f 55 154 23.19 Tb abdomen diag laproscopy bupivacaine 80 102 110 108 110 107 102 102 99 98 97 98 94 119 102 98 115 136 137 132 116 117 116 117 98 100 106 107 129 120 116 74 77 72
20 sathish kumar 23 m 60 152 25.97 sub ac appendicitis lap appendicectomy bupivacaine 60 78 77 78 66 78 78 88 76 102 88 88 78 76 99 76 132 137 122 125 128 127 123 124 158 123 122 123 125 124 123 77 73 72
21 manikandan 24 m 70 170 24.22 sub ac appendicitis lap appendicectomy bupivacaine 60 86 86 87 87 77 89 80 90 91 87 95 81 102 82 74 110 116 115 112 114 117 127 123 112 115 118 128 150 117 110 78 76 88
22 dorathi 31 f 60 140 30.61 sub ac appendicitis lap appendicectomy bupivacaine 70 58 66 69 66 65 65 58 57 55 99 90 56 56 56 55 102 103 110 100 98 96 98 102 104 143 106 108 104 106 110 82 81 82
23 mahesh 24 m 55 160 21.48 sub ac appendicitis lap appendicectomy bupivacaine 80 76 78 68 67 67 76 79 78 88 87 110 110 122 121 110 118 119 118 110 112 110 118 121 112 117 150 123 110 113 113 78 66 68
24 vijay 35 m 60 160 23.44 Tb abdomen diag laproscopy bupivacaine 40 88 102 104 99 98 88 83 82 84 110 88 86 82 78 87 140 142 144 142 131 110 121 122 123 148 122 122 132 112 113 88 92 94
25 senthil 22 m 50 158 20.03 Tb abdomen diag laproscopy bupivacaine 60 88 76 78 79 80 82 88 87 88 76 99 76 77 78 78 130 130 132 131 130 126 127 122 124 121 149 122 127 124 121 70 72 76
26 savithri 38 f 60 140 30.61 sub ac appendicitis lap appendicectomy bupivacaine 40 88 102 104 99 98 88 83 82 84 110 88 86 82 78 87 140 142 144 142 131 110 121 122 123 148 122 122 132 112 113 88 92 94
27 anjaneyan 31 m 45 158 18.03 sub ac appendicitis lap appendicectomy bupivacaine 50 89 87 86 76 72 72 72 72 99 82 86 87 86 87 85 121 111 116 117 113 115 126 115 141 112 115 117 115 111 119 79 78 79
28 mahalakshmi 23 f 35 140 17.86 adhesive colitis lap adhesiolysis bupivacaine 25 112 115 102 98 97 96 96 97 97 110 98 92 88 88 89 102 126 133 124 122 121 121 118 115 149 113 116 118 116 119 88 95 88
29 duraivelu 25 m 65 165 23.88 sub ac appendicitis lap appendicectomy bupivacaine 80 95 98 97 92 88 88 87 88 76 78 110 88 84 91 82 116 115 117 118 116 117 118 120 121 122 149 121 107 104 108 88 67 66
30 tamilarasi 32 f 58 160 22.66 cal cholecystitis lap cholecystectomy bupivacaine 105 110 108 110 110 104 102 102 101 100 103 102 101 101 110 100 125 131 121 120 128 110 116 110 108 110 106 110 106 129 110 83 81 77
31 kumar 38 m 70 170 24.22 sub ac appendicitis lap appendicectomy ropivacaine 60 85 94 91 88 77 68 82 84 89 78 76 87 88 100 89 119 138 13 132 134 120 144 112 123 123 114 116 107 102 144 88 87 88
32 balagurusamy 42 m 70 175 22.86 cal cholecystitis lap cholecystectomy ropivacaine 70 76 78 72 76 77 77 74 72 74 77 102 77 76 74 73 121 113 128 126 119 121 118 119 127 123 138 117 109 104 112 66 64 72
33 vijayalakshmi 30 m 79 165 29.02 cal cholecystitis lap cholecystectomy ropivacaine 200 119 105 102 106 98 99 93 92 88 88 119 102 89 89 98 140 142 144 132 136 131 129 135 136 137 160 136 133 132 118 92 90 94
34 mariya 51 f 62 145 29.49 cal cholecystitis lap cholecystectomy ropivacaine 60 78 72 81 76 77 74 72 99 77 75 72 72 98 71 110 130 134 128 136 134 140 130 140 132 128 150 131 136 122 150 90 97 92
35 sathish kumar 22 m 60 150 26.67 sub ac appendicitis lap appendicectomy ropivacaine 50 96 97 82 89 91 76 110 78 77 79 81 84 77 72 77 110 110 112 114 100 102 140 102 110 102 124 124 113 113 112 82 84 78
36 tamilselvi 34 f 50 150 22.22 sub ac appendicitis lap appendicectomy ropivacaine 35 104 102 89 87 86 88 87 80 79 77 80 79 112 128 80 142 139 110 112 112 116 108 110 112 108 108 112 112 128 130 90 89 87
37 nathiya 25 f 50 152 21.64 cal cholecystitis lap cholecystectomy ropivacaine 30 80 78 76 72 74 72 66 69 88 67 76 66 62 68 79 130 130 131 110 116 117 98 99 130 98 99 92 90 92 100 93 94 78
38 divya 17 f 30 151 13.16 sub ac appendicitis lap appendicectomy ropivacaine 30 98 100 97 96 100 102 120 110 108 106 104 98 99 98 102 98 124 122 116 120 130 136 150 122 119 117 120 122 121 121 75 76 78
39 mary 29 f 65 150 28.89 cal cholecystitis lap cholecystectomy ropivacaine 40 96 97 82 89 91 76 110 78 77 79 81 84 77 72 77 110 110 112 114 100 102 140 102 110 102 124 124 113 113 112 82 84 78
40 inbakumari 26 f 55 148 25.11 sub ac appendicitis lap appendicectomy ropivacaine 80 82 81 82 80 78 80 88 78 81 78 99 88 88 76 76 122 121 120 116 110 100 112 108 106 104 120 103 100 110 110 68 68 67
41 sarhishwari 33 f 65 144 31.35 sub ac appendicitis lap appendicectomy ropivacaine 65 109 90 92 83 82 89 91 87 105 75 76 77 78 76 73 130 133 133 126 126 125 122 115 116 140 126 110 100 100 102 80 87 88
42 vijayalakshmi 35 f 60 146 28.15 cal cholecystitis lap cholecystectomy ropivacaine 70 78 90 99 96 78 80 78 80 82 89 82 88 86 88 100 123 144 143 128 120 124 126 110 112 121 116 117 110 118 140 88 95 94
43 thulasi 36 f 70 148 31.96 cal cholecystitis lap cholecystectomy ropivacaine 150 70 89 88 78 78 79 77 76 76 75 98 77 76 75 73 131 139 132 131 123 122 123 125 122 125 126 121 114 115 150 87 87 88
44 satham hussain 19 m 65 170 22.49 sub ac appendicitis lap appendicectomy ropivacaine 75 88 90 92 92 79 78 77 76 66 86 87 89 78 110 78 142 141 142 141 120 122 128 126 127 123 128 122 127 150 122 78 80 81
45 surendean 23 m 65 172 21.97 sub ac appendicitis lap appendicectomy ropivacaine 60 68 76 78 79 80 99 89 86 78 76 88 87 76 77 77 132 123 122 123 139 130 150 140 133 123 126 128 129 127 129 88 87 83
46 jessi prema 18 f 50 152 21.64 sub ac appendicitis lap appendicectomy ropivacaine 45 70 73 72 74 78 77 76 98 77 77 73 76 75 72 72 120 122 129 125 123 123 123 150 128 123 118 119 117 121 121 85 84 84
47 raji 30 f 45 148 20.54 sub ac appendicitis lap appendicectomy ropivacaine 90 78 88 94 98 87 88 86 85 98 77 78 76 78 71 76 112 125 122 116 116 112 122 121 139 121 119 118 117 116 120 76 77 76
48 ammini 29 f 70 154 29.52 cal cholecystitis lap cholecystectomy ropivacaine 80 90 88 90 92 91 88 92 78 76 75 73 66 65 65 63 110 110 112 108 110 109 140 109 102 105 104 102 104 109 110 78 72 77
49 anbarasi 27 f 50 156 20.55 cal cholecystitis lap cholecystectomy ropivacaine 50 96 97 82 89 91 76 110 78 77 79 81 84 77 72 77 110 110 112 114 100 102 140 102 110 102 124 124 113 113 112 82 84 78
50 ponnuthai 40 f 45 148 20.54 cal cholecystitis lap cholecystectomy ropivacaine 30 78 79 78 87 75 76 73 76 98 77 77 73 76 75 72 110 110 110 112 114 100 102 122 128 126 127 123 128 122 127 80 87 88
51 suganya 19 f 35 142 17.36 cal cholecystitis lap cholecystectomy ropivacaine 110 70 89 88 78 78 79 77 76 76 75 98 77 76 75 73 131 139 132 131 123 122 123 125 122 125 126 121 114 115 150 87 87 88
52 devi 34 f 60 155 24.97 cal cholecystitis lap cholecystectomy ropivacaine 60 78 72 81 76 77 74 72 99 77 75 72 72 98 71 110 130 134 128 136 134 140 130 140 132 128 150 131 136 122 150 90 97 92
53 balamurugan 24 f 67 156 27.53 sub ac appendicitis lap appendicectomy ropivacaine 50 96 97 82 89 91 76 110 78 77 79 81 84 77 72 77 110 110 112 114 100 102 140 102 110 102 124 124 113 113 112 82 84 78
54 kannan 28 m 70 170 24.22 sub ac appendicitis lap appendicectomy ropivacaine 60 90 92 88 77 76 76 73 92 73 75 72 71 72 77 98 119 145 124 122 115 109 110 129 116 100 110 122 112 112 116 91 65 78
55 shakila 26 f 55 160 21.48 sub ac appendicitis lap appendicectomy ropivacaine 80 82 81 82 80 78 80 88 78 81 78 99 88 88 76 76 122 121 120 116 110 100 112 108 106 104 120 103 100 110 110 68 68 67
56 padmavathi 33 f 65 152 28.13 sub ac appendicitis lap appendicectomy ropivacaine 65 109 90 92 83 82 89 91 87 105 75 76 77 78 76 73 130 133 133 126 126 125 122 115 116 140 126 110 100 100 102 80 87 88
57 neela 35 f 60 151 26.31 cal cholecystitis lap cholecystectomy ropivacaine 70 78 90 99 96 78 80 78 80 82 89 82 88 86 88 100 123 144 143 128 120 124 126 110 112 121 116 117 110 118 140 88 95 94
58 devi 36 f 70 152 30.3 cal cholecystitis lap cholecystectomy ropivacaine 150 70 89 88 78 78 79 77 76 76 75 98 77 76 75 73 131 139 132 131 123 122 123 125 122 125 126 121 114 115 150 87 87 88
59 anand 19 m 65 158 26.04 sub ac appendicitis lap appendicectomy ropivacaine 75 88 90 92 92 79 78 77 76 66 86 87 89 78 110 78 142 141 142 141 120 122 128 126 127 123 128 122 127 150 122 78 80 81
60 arivu 23 m 65 156 26.71 sub ac appendicitis lap appendicectomy ropivacaine 60 68 76 78 79 80 99 89 86 78 76 88 87 76 77 77 132 123 122 123 139 130 150 140 133 123 126 128 129 127 129 88 87 83
61 venkatesan 55 m 60 178 18.94 cal cholecystitis lap cholecystectomy control 100 110 78 76 75 106 113 98 99 97 88 88 89 102 98 113 130 142 141 134 144 141 137 132 132 126 134 142 150 122 134 80 99 98
62 sameera 19 f 35 160 13.67 sub ac appendicitis lap appendicectomy control 80 90 118 116 121 110 99 110 112 102 98 99 96 98 92 110 110 140 142 136 154 134 152 134 132 151 134 123 156 133 123 78 88 78
63 prama 53 m 64 158 25.64 cal cholecystitis lap cholecystectomy control 55 97 97 92 98 88 92 100 110 108 98 112 92 88 98 118 102 132 134 123 124 125 144 131 134 132 153 122 123 145 132 80 87 87
64 kanthamani 55 m 60 170 20.76 sub ac appendicitis lap appendicectomy control 60 82 78 76 76 76 78 78 83 78 78 77 78 97 92 99 130 125 126 124 122 138 121 118 140 121 123 140 122 134 123 80 82 78
65 chellammal  52 f 60 156 24.65 sub ac appendicitis lap appendicectomy control 100 92 88 87 86 78 78 77 88 102 78 72 76 87 88 87 130 148 123 122 123 143 123 132 133 125 123 145 144 123 123 90 88 89
66 arul 30 m 60 170 20.76 sub ac appendicitis lap appendicectomy control 120 80 98 99 96 96 94 92 98 88 98 86 97 90 98 99 130 149 148 145 142 132 119 120 121 136 131 122 122 123 123 78 102 103
67 suganthi 18 f 55 140 28.06 sub ac appendicitis lap appendicectomy control 70 88 87 84 84 86 88 78 87 89 88 88 88 88 99 90 122 128 126 126 124 132 122 124 127 128 134 132 125 124 132 80 78 78
68 vennila 22 f 50 154 21.08 Tb abdomen diag laproscopy control 55 88 104 103 103 102 102 101 111 98 98 97 92 97 98 98 123 144 144 142 141 140 140 142 133 132 136 132 123 134 124 88 84 83
69 giri 34 f 55 155 22.89 sub ac appendicitis lap appendicectomy control 70 88 104 103 103 102 102 101 111 98 98 97 92 97 98 98 123 144 144 142 141 140 140 142 133 132 136 132 123 134 124 88 84 83
70 arjun 47 m 50 170 17.3 sub ac appendicitis lap appendicectomy control 120 92 88 87 86 78 78 77 88 102 78 72 76 87 88 87 130 148 123 122 123 143 123 132 133 125 123 145 144 123 123 90 88 89
71 thiyagarajan 30 m 55 160 21.48 sub ac appendicitis lap appendicectomy control 80 88 98 99 96 96 94 92 98 88 98 86 97 90 98 99 130 149 148 145 142 132 119 120 121 136 131 122 122 123 123 78 102 103
72 vennila 32 f 50 154 21.08 sub ac appendicitis lap appendicectomy control 110 92 87 84 84 86 88 78 87 89 88 88 88 88 99 90 122 128 126 126 124 132 122 124 127 128 134 132 125 124 132 80 78 78
73 caroline 50 m 55 156 22.6 cal cholecystitis lap cholecystectomy control 80 78 80 83 78 87 74 78 76 78 88 79 78 80 78 78 132 144 140 146 144 138 136 138 132 124 132 126 125 143 140 82 88 86
74 sugantha 28 f 66 160 25.78 sub ac appendicitis lap appendicectomy control 80 98 98 92 94 93 92 78 76 77 75 77 98 99 102 100 122 121 124 122 134 135 135 136 133 128 144 146 141 136 140 78 77 78
75 anbarasi 27 f 50 160 19.53 sub ac appendicitis lap appendicectomy control 60 80 82 89 76 78 80 82 88 89 89 87 87 88 90 78 100 140 125 112 128 126 114 118 142 147 127 125 103 119 117 60 99 90
76 munusamy 45 M 50 158 20.03 sub ac appendicitis lap appendicectomy control 70 92 88 87 86 78 78 77 88 102 78 72 76 87 88 87 130 148 123 122 123 143 123 132 133 125 123 145 144 123 123 90 88 89
77 kalidoss 26 M 58 168 20.55 cal cholecystitis lap cholecystectomy control 80 88 98 99 96 96 94 92 98 88 98 86 97 90 98 99 130 149 148 145 142 132 119 120 121 136 131 122 122 123 123 78 102 103
78 sampath 55 M 60 170 20.76 sub ac appendicitis lap appendicectomy control 110 92 87 84 84 86 88 78 87 89 88 88 88 88 99 90 122 128 126 126 124 132 122 124 127 128 134 132 125 124 132 80 78 78
79 murugan 39 M 50 175 16.33 sub ac appendicitis lap appendicectomy control 75 78 80 83 78 87 74 78 76 78 88 79 78 80 78 78 132 144 140 146 144 138 136 138 132 124 132 126 125 143 140 82 88 86
80 gopi kannan 20 M 60 176 19.37 sub ac appendicitis lap appendicectomy control 80 98 98 92 94 93 92 78 76 77 75 77 98 99 102 100 122 121 124 122 134 135 135 136 133 128 144 146 141 136 140 78 77 78
81 dhanalakshmi 55 F 58 155 24.14 cal cholecystitis lap cholecystectomy control 75 80 82 89 76 78 80 82 88 89 89 87 87 88 90 78 100 140 125 112 128 126 114 118 142 147 127 125 103 119 117 60 99 90
82 durai raj 55 M 60 160 23.44 sub ac appendicitis lap appendicectomy control 100 72 102 110 108 116 112 98 92 99 96 94 92 93 91 88 100 133 132 133 135 136 128 122 128 130 130 140 128 126 128 76 90 90
83 thendral 23 M 62 158 24.84 sub ac appendicitis lap appendicectomy control 110 72 90 92 91 88 87 86 78 77 78 90 92 93 86 76 106 140 140 132 122 132 123 124 127 121 124 126 139 129 132 72 88 89
84 devi 32 f 60 160 23.44 cal cholecystitis lap cholecystectomy control 75 72 96 98 99 98 96 92 88 85 86 84 76 88 87 89 121 142 148 147 142 144 132 121 108 106 110 119 118 113 131 70 90 89
85 kumari devi 28 f 55 166 19.96 Tb abdomen diag laproscopy control 55 70 98 94 99 88 78 76 75 77 76 77 82 77 73 78 120 139 138 132 133 131 123 121 118 102 104 104 106 110 112 60 92 91
86 priya 32 f 55 158 22.03 sub ac appendicitis lap appendicectomy control 60 71 88 87 86 84 78 78 75 86 85 73 72 71 70 88 118 113 118 119 109 106 104 98 96 99 98 98 98 100 102 70 77 68
87 selvi 27 f 58 150 25.78 sub ac appendicitis lap appendicectomy control 70 72 90 92 91 88 87 86 78 77 78 90 92 93 86 76 106 140 140 132 122 132 123 124 127 121 124 126 139 129 132 72 88 89
88 devika 41 f 58 159 22.94 cal cholecystitis lap cholecystectomy control 150 72 96 98 99 98 96 92 88 85 86 84 76 88 87 89 121 142 148 147 142 144 132 121 108 106 110 119 118 113 131 70 90 89
89 basha 44 m 68 172 22.99 cal cholecystitis lap cholecystectomy control 130 70 98 94 99 88 78 76 75 77 76 77 82 77 73 78 120 139 138 132 133 131 123 121 118 102 104 104 106 110 112 60 92 91
90 parasuraman 34 m 70 168 24.8 sub ac appendicitis lap appendicectomy control 70 72 97 97 96 88 85 98 99 102 98 97 95 94 92 93 110 131 132 129 127 121 110 108 121 122 110 110 109 108 117 68 89 89
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